<DOC>
	<DOC>NCT02795325</DOC>
	<brief_summary>A phase 1 study of DCR-PH1 in patients with primary hyperoxaluria type 1 (PH1) to determine the safety, tolerability, pharmacokinetic (PK) and pharmacodynamics (PD) effects of DCR-PH1 administered via-intravenous infusion (IV)</brief_summary>
	<brief_title>A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)</brief_title>
	<detailed_description />
	<mesh_term>Hyperoxaluria, Primary</mesh_term>
	<criteria>Male or female, at least 12 years of age Diagnosis of PH1, confirmed by genotyping 24hour urine oxalate excretion as defined in the protocol eGFR ≥ 40 mL/min normalized to 1.73 m2 BSA Written informed consent for adults (≥18 years old, or per local regulatory requirement); written informed assent for adolescents (12 to &lt;18 years old, or per local regulatory requirement) Prior renal and/or hepatic transplantation Participation in any clinical study involving administration of any investigational drug within the 30 days before enrollment Pregnancy or lactation at the time of screening or enrollment Women of childbearing potential must have a negative pregnancy test, cannot be breastfeeding and must be willing to use contraception Patients with a known history of human immunodeficiency virus (HIV) or active infection with hepatitis B virus or hepatitis C virus Moderate to severe liver impairment Liver function test abnormalities: alanine transaminases (ALT) and/or aspartate transaminases (AST) &gt; 2 times upper limit of normal (ULN) History of severe reaction to a liposomal product or a known hypersensitivity to lipid products. Unable to collect required study samples or follow study procedures No clinically significant health concerns</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Primary Hyperoxaluria Type 1</keyword>
	<keyword>PH1</keyword>
	<keyword>Calcium Oxalate Stones</keyword>
	<keyword>Kidney Stones</keyword>
	<keyword>Liver Enzyme Deficiency</keyword>
	<keyword>Genetic Diseases</keyword>
	<keyword>Inborn Kidney Diseases</keyword>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Inborn Errors</keyword>
	<keyword>Urological Diseases</keyword>
	<keyword>Carbohydrate Metabolism</keyword>
	<keyword>Hyperoxaluria</keyword>
	<keyword>AGT</keyword>
	<keyword>RNAi</keyword>
	<keyword>siRNA</keyword>
	<keyword>DCR-PH1</keyword>
</DOC>